참고문헌
- Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest 1988;81:277-281 https://doi.org/10.1172/JCI113318
- Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilate remodeling, ossification and angiogenesis during endochondral ossification. Nature Med 1999;5:623-628 https://doi.org/10.1038/9467
- Horner A, Bishop NJ, Bord S, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 1999;194:519-524 https://doi.org/10.1046/j.1469-7580.1999.19440519.x
- Ryan AM, Eppler DB, Hagler KE, et al. Preclinical safety evaluation of rhuMabVEGF, an angiangiogenic humanized monoclonal antibody. Toxicol Pathol 1999;27:78-86 https://doi.org/10.1177/019262339902700115
- Clavel G, Bessis N, Boissier MC. Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003;70:321-326 https://doi.org/10.1016/S1297-319X(03)00088-5
- Harper J, Klagsbrun M. Cartilage to boneangiogenesis leads the way. Nature Med 1999;5:617-618 https://doi.org/10.1038/4694
- Davis S, Aldrich TH, Jones PF, et al. Isolation of agniopoietin-1, a ligand for the TIE1 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169 https://doi.org/10.1016/S0092-8674(00)81812-7
- Asahara T, Chen DH, Takahashi T, et al. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnasal neovasculaisation. Circulation Res 1998;83:233-240 https://doi.org/10.1161/01.RES.83.3.233
- Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60 https://doi.org/10.1126/science.277.5322.55
- Kim I, Kim JH, Ryu YS, Liu M, Koh GY. Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2000;269:361-365 https://doi.org/10.1006/bbrc.2000.2296
- Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for Tie2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-1180 https://doi.org/10.1016/S0092-8674(00)81813-9
- Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, Sessa WC. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 1999;79:213-223 https://doi.org/10.1111/1523-1747.ep12500063
- Yuan HT, Suri C, Yancopoulos GD, Woolf AS. Expression of angiopoietin-1, angiopoietin-2, and the tie2 receptor tyrosine kinase during mouse kidney maturation. J Am Soc Nephrol 1999;10:1722-1736
- Horner A, Bord S, Kelsall AW, Coleman N, Compston JE. Tie2 ligand angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. Bone 2001;28:65-71 https://doi.org/10.1016/S8756-3282(00)00422-1
- Siffert RS. The role of alkaline phosphatase in osteogenesis. J Exp Med 1951;93:415-422 https://doi.org/10.1084/jem.93.5.415
- Fauran-Clavel MJ, Oustrin J. Alkaline phosphatase and bone calcium parameters. Bone 1986;7:95-99 https://doi.org/10.1016/8756-3282(86)90680-0
- Nijweide PJ, Burger EH, Feyen JHM. Cells of bone:Proliferation, differentiation, and hormonal regulation. Physiol Rev 1986;66:855-886 https://doi.org/10.1152/physrev.1986.66.4.855
- Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-463 https://doi.org/10.1002/bies.950140705
- Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999;43:S42-S51 https://doi.org/10.1007/s002800051097
- Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzyme required for extracellular matrix digestion. Circ Res 1994;75:181-189 https://doi.org/10.1161/01.RES.75.1.181
- Johnson JL, van Eys GJ, Angelini GD, George SJ. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 2001;21:1146-1151 https://doi.org/10.1161/hq0701.092106
- Hu B, Guo P, Fang Q, et al. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. PNAS 2003;100:8904-8909 https://doi.org/10.1073/pnas.1533394100
- Das A, Fanslow W, Cerretti D, Warren E, Talarico N, McGuire P. Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Lab Invest 2003;83:1637-1645 https://doi.org/10.1097/01.LAB.0000097189.79233.D8
- Danziger R, Zuckerbraun B, Pensler J. Role of nitric oxide in the regulation of osteoblast metabolism. Plastic and Reconstruc Surg 1997;100:670-673 https://doi.org/10.1097/00006534-199709000-00020
- Takahashi N, Yamana H, Yoshiki S, et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinol 1988;122:1373-1382 https://doi.org/10.1210/endo-122-4-1373
-
Takahashi N, Akastu T, Sasaki T, et al. Induction of calcitonin receptors by 1
$\alpha$ ,25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinol 1988;123:1504-1510 https://doi.org/10.1210/endo-123-3-1504 -
Sasaki T, Takahashi N, Higashi S, Suda T. Multinucleated cells formed on calcified dentin from mouse bone marrow cells treated with 1
$\alpha$ ,25-dihydroxyvitamin D3 have ruffled borders and resorb dentin. Anat Rec 1989;224:379-391 https://doi.org/10.1002/ar.1092240307 - Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-290 https://doi.org/10.1007/BF02411252